14:42 , May 20, 2019 |  BC Extra  |  Financial News

May 20 Financial Quick Takes: Schrödinger tops off E round; plus Mabpharm IPO update, DNA Script, ADMA Biologics, Storm

Schrödinger brings E round to $110M  Computational physics company Schrödinger LLC (New York, N.Y.) closed the second tranche of its total $110 million series E round to support development of its technology platform and expand...
19:54 , May 13, 2019 |  BC Extra  |  Financial News

May 13 Financial Quick Takes: Biotech trio update IPO plans, plus Vedanta, TreeFrog

Peloton, Ideaya, Bicycle set IPO terms  Peloton Therapeutics Inc. (Dallas, Texas) was among three biotechs amending proposed IPOs on NASDAQ. The HIF2A company plans to sell 9.4 million shares at $15-$17. If priced at the...
23:54 , May 8, 2019 |  BC Extra  |  Company News

May 8 Company Quick Takes: Takeda selling Shire eye drug to Novartis in $3.4B deal; plus BioNTech, Third Rock’s Thrive and more

Takeda off-loads Xiidra, TachoSil  Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK) will sell Xiidra lifitegrast to Novartis AG (NYSE:NVS; SIX:NOVN) for $3.4 billion up front, plus $1.9 billion in milestones. Takeda said divesting the dry eye...
21:34 , May 8, 2019 |  BC Extra  |  Financial News

CRO Viva raises $193.9 million in Hong Kong IPO

Viva will begin trading Thursday after raising HK$1.5 billion (US$193.9 million) early Wednesday in an IPO that values the drug discovery services company at HK$6.6 billion (US$843.1 million). Viva Biotech Holdings (HKSE:1873) sold 345 million...
17:34 , May 3, 2019 |  BC Extra  |  Financial News

With potential launches nearing, Zai taps investors for $200M

Eight months after raising $150 million in a follow-on, Zai has returned to the well to raise $200 million in an upsized offering as it prepares for a pair of potential launches in mainland China....
23:32 , Apr 30, 2019 |  BC Extra  |  Financial News

April 30 Financial Quick Takes: Mustang, Tot Biopharm, Axcella and more

Mustang raises $27.5M after gene therapy data Mustang Bio Inc. (NASDAQ:MBIO) raised $27.5 million in a follow-on underwritten by Cantor Fitzgerald, Oppenheimer, H.C. Wainwright and Roth Capital. The offering comes on the heels of positive...
22:45 , Apr 29, 2019 |  BC Extra  |  Financial News

April 29 Quick Takes: Sirnaomics, Codiak, Cortexyme, Milestone, NextCure, Applied Therapeutics, Magenta

Sirnaomics closes $47M series C  RNAi therapeutics company Sirnaomics Inc. (Gaithersburg, Md.) raised $22 million in a series C2 round led by Hong Kong-based CR-CP Life Sciences Fund, closing out its series C round for...
20:07 , Apr 26, 2019 |  BC Week In Review  |  Financial News

CRO Viva could get $749M valuation in Hong Kong listing, Ascentage refiles

Viva would raise HK$1.4 billion ($172.2 million) and be valued at HK$5.9 billion ($748.7 million) if the drug discovery services company prices its Hong Kong IPO at the midpoint of the range it proposed April...
03:36 , Apr 18, 2019 |  BC Extra  |  Financial News

Hookipa raises $84M in IPO

Hookipa raised $84 million in an IPO on NASDAQ late Wednesday, pricing at the bottom of its range and selling fewer shares than the company had hoped. Hookipa Pharma Inc. (NASDAQ:HOOK) sold 6 million shares...
23:04 , Apr 17, 2019 |  BC Extra  |  Financial News

Biotech indexes tumble in preview of campaign volatility

Biotech indexes tumbled on Wednesday as presidential primary rhetoric weighed on biopharma shares. The rout came a day after UnitedHealth Group Inc. (NYSE:UNH) CEO David Scott Wichmann waded into the Medicare For All debate, sending...